pubrio
NMPA-National Medical Products Administration logo

NMPA-National Medical Products Administration

Government Agency
nmpa.gov.cn
健康與人類服務4 employeesFounded 1950🇨🇳 中國

Main Responsibilities of the National Medical Products Administration (1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics. (2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system. (3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof. (4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA's responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.

成立年份
1950
員工
4
行業
健康與人類服務
公司類型
Government Agency
總部
🇨🇳Beijing, Beijing
專長
健康與人類服務
4 / 13
活躍市場
2
新市場
MO · TW
信心度
大多為早期訊號
+300%
動能
對比上一週期
19 / 100
擴張評分
初期
階段12探索中1投入中
5 個訊號 · 過去 90 日

全球擴張

即時
HKAUJP
階段
探索中投入中進入中營運中
+10個市場已鎖定
已顯示 13 個中的 3 個

解鎖市場時間軸與訊號動態

活動脈搏

全新 合作夥伴 活動 — 剛出現 3 個新訊號。

過去 90 日
招聘
0
無活動
市場推廣與公關
0
無活動
產品與技術
2
產品發布
+2個類別已鎖定
已顯示 5 個中的 3 個

市場進入時間軸

此公司進入各市場的次序 — 由最舊至最新

1
🇭🇰HK第 1st 個進入的市場 · 2025推進中
投入中
14 個訊號投入中 階段
2
🇦🇺AU第 2nd 個進入的市場 · 2025推進中
探索中
6 個訊號探索中 階段
3
🇯🇵JP第 3rd 個進入的市場 · 2025推進中
探索中
4 個訊號探索中 階段
+10個市場已鎖定
已顯示 13 個中的 3 個
目前階段投入中投入資源
信心度41%
開始追蹤於2025首個訊號

近期訊號

產品發布🇭🇰 HK2星期前

安騰基因獲CDE批准進行ATG-022三期試驗

合作夥伴🇭🇰 HK上個月

科倫博泰獲SKB118臨床試驗批准

註冊以查看完整訊號動態

值得了解

關於 NMPA-National Medical Products Administration 的常見問題

關於 NMPA-National Medical Products Administration 業務、市場及增長訊號的快速解答。

Main Responsibilities of the National Medical Products Administration (1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics. (2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system. (3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof. (4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA's responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。